Zila, Inc.'s Chief Executive Officer to Present at the 5th Annual MicroCapital Conference
May 12 2006 - 8:30AM
Business Wire
Douglas D. Burkett, Ph.D., Chairman, Chief Executive Officer and
President, of Zila, Inc. (Nasdaq: ZILA), an innovator in
preventative healthcare technologies and products will be
presenting at the 5th Annual MicroCapital Conference at the Harvard
Club in New York City. Dr. Burkett's presentation will be held
Thursday, May 18, at 2:20 p.m. E.T. and will include an overview of
the Company and its recent milestones. The presentation will be
filmed and available on MicroCapital's website,
www.microcapital.com beginning May 25th. About Zila, Inc. Zila,
Inc., headquartered in Phoenix, is an innovator in preventative
healthcare technologies and products, focusing on enhanced body
defense and the detection of pre-disease states. Zila has three
business units: -- Zila Biotechnology, a research, development and
licensing business specializing in pre-cancer/cancer detection
through its patented Zila(R) Tolonium Chloride and OraTest(R)
technologies. -- Zila Pharmaceuticals, marketer of products to
promote oral health and prevent oral disease, including ViziLite(R)
Plus oral examination kits and Peridex(R) prescription periodontal
rinse. -- Zila Nutraceuticals, manufacturer and marketer of
Ester-C(R) and Ester-E(R), branded, highly effective forms of
Advanced Protection vitamins C and E. -- For more information about
Zila, visit www.zila.com. This press release contains
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. These forward-looking statements are based largely on
Zila's expectations or forecasts of future events, can be affected
by inaccurate assumptions and are subject to various business risks
and known and unknown uncertainties, a number of which are beyond
the Company's control. Therefore, actual results could differ
materially from the forward-looking statements contained herein. A
wide variety of factors could cause or contribute to such
differences and could adversely impact revenues, profitability,
cash flows and capital needs. There can be no assurance that the
forward-looking statements contained in this press release will, in
fact, transpire or prove to be accurate. For a more detailed
description of these and other cautionary factors that may affect
Zila's future results, please refer to Zila's Form 10-K for its
fiscal year ended July 31, 2005.
Zila (NASDAQ:ZILA)
Historical Stock Chart
From May 2024 to Jun 2024
Zila (NASDAQ:ZILA)
Historical Stock Chart
From Jun 2023 to Jun 2024